Vaccine adjuvants have evolved significantly since their inception, transitioning from empirical discovery to a more structured approach grounded in rational drug design. The origin of vaccine ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Asha Therapeutics has announced its rebranding as First Atom Therapeutics (“First Atom”), marking the company’s evolution as a zero-shot de novo drug design company using AI-enabled molecular design ...

Ethan Grimes, BS, and Paul Morgan, MD, conduct rational drug design at the newly launched AI Small Molecule Drug Discovery Center at the Icahn School of Medicine at Mount Sinai. As part of Mount Sinai ...

Dr. Khaled Elokely specializes in the integration of computational and medicinal chemistry for innovative drug design and development at the University of Wyoming. With a background in pharmaceutical ...

There are about 46,000 organ transplants performed a year in the US; their success is, in considerable measure, due to the pioneering work of Gertrude Elion.

Acrivon Therapeutics, Inc. ('Acrivon” or 'Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company ...

Malaria remains a major global health burden, and the continued emergence of resistance to frontline therapies, including artemisinin-based combination ...

The Icahn School of Medicine at Mount Sinai launched the AI Small Molecule Drug Discovery Center which was created to integrate AI with traditional drug discovery methods to identify and design new ...